ImmunityBio
Rashmi Ramaswamy Nadig is a skilled business analyst currently serving as the Lead Business Analyst for Clinical and Regulatory at ImmunityBio, Inc., specializing in process improvement and comprehensive business mapping. Previously, Rashmi held multiple senior associate roles at Amgen, focusing on operations digital technology, global regulatory affairs, and safety, where contributions included optimizing supply chain processes and enhancing regulatory activities. Additional experience includes research positions at prestigious institutions, such as the Keck School of Medicine of USC and Arizona State University, involving advanced imaging, neuroprosthetics, and electrochemical sensor development. Rashmi holds a Master's degree in Biomedical Engineering from the University of Southern California and a Bachelor's degree in Biotechnology from PES University.
This person is not in the org chart
ImmunityBio
4 followers
ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.